Dr Parminder J Singh is a specialist knee orthopaedic surgeon who provides knee pain treatment. The surgical treatment includes knee arthroscopy (including anterior cruciate ligament reconstruction, patella and quadriceps tendon repair), knee pain front, minimally invasive and rapid recovery joint replacement surgery using some of the latest techniques including robotic knee surgery techniques.  Dr Singh, knee specialist, also provides some injections treatment (Duralane) for patients with early knee arthritis to help with pain management.

Dr Singh is currently performing his surgery at St Vincent’s Private East Melbourne, Epworth Richmond Private Hospital, Epworth Eastern Private Hospital and Waverley Private Hospital.

Injectable treatment for early knee early arthritis

Osteoarthritis (OA) is considered as one of the main causes of functional disability in humans. The patient with OA is suffering not only from the persistent pain, stiffness and limited mobility, moreover, it also directly affects their quality of life.

Recommendations for OA management, includes non-pharmacological such as patient education and awareness, physical exercise and rehabilitation aids.
The pharmacological modalities vary from prescription of non-selective NSAIDs (Nonsteroidal anti-inflammatory drugs) and selective COX-2 inhibitors agents and in some cases even opioid type medication. NSAIDs are the most prescribed medicine for OA. Despite NSAIDs established effectiveness in relieving the pain with OA its long term use is associated with potential harmful adverse effects.

The other potential non-operative therapeutic methods are chondroitin sulfate, glucosamine, and intra-articular injections of visco-supplements, corticosteroids, or blood-derived products. Over the last decades, there is an ongoing trend to use Intra-articular injections of either corticosteroids, analgesics/anti-inflammatory drugs, polymerized collagen, anti-cytokine drugs, or hyaluronic acid as alternative modalities to maximize the topical effect and minimize the systemic adverse effects. Each injection has been shown to lower the pain in patients in some form, though hyaluronic acid treatments using Duralane® seem to be amongst the safest and effective.

Indications for Duralane®

DUROLANE® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to simple pain relief and conservative management.

What is Duralane?

DUROLANE® is a viscous gel of highly purified, stabilized, non-animal-derived sodium hyaluronate that is made using bacterial fermentation. Technology is used to stabilize naturally entangled hyaluronic acid (HA) chains to produce a gel.

What are the Benefits of Duralane?

A single injection of DUROLANE® provides a benefit for pain reduction in patients with osteoarthritis in the knee for up to 26 weeks.

Post Injection Instructions

Temporary pain or swelling of the injected joint may occur after the injection with DUROLANE®.
Patient’s should avoid any strenuous activities or prolonged (i.e. more than an hour) weight bearing activities within 48 hours following their injection.

Potential Side Effects

The most common side effect, being a transient acute post-injection local joint irritation. Injection related inflammation (synovitis) can be observed in approximately 5–10% of individuals undertaking this treatment, but these reactions are characteristically temporary without longer-term clinical effects.

Download Brouchure

Book a Consultation

Committed to improving the quality of patient advice, treatment and care in the field of orthopaedics, book a one-on-one consultation with Dr Parminder J Singh today.

Book A Consultation
Opt in for newsletter?

Consulting Locations

21 Erin St, Richmond VIC 3121 Book a consultation on: (03) 9428 4128
85 Wilson St, Brighton VIC 3186 Book a consultation on: (03) 9428 4128
Suite 1G, 116-118 Thames St, Boxhill VIC 3128 Book a consultation on: (03) 9428 4128
Waverly Private Hospital, 343-357 Blackburn Rd, Mount Waverley VIC 3149 Book a consultation on: (03) 9428 4128